Advertisement
Advertisement
BAX
Baxter International Inc.
27.01
USDSponsored
-0.32
-1.17%
Aug 06, 16:00 UTC -4
Closed
Pre-Market
27.02
+0.01
+0.06%
BAX Earnings Reports
Positive Surprise Ratio
BAX beat 34 of 42 last estimates.
81%
Next Report
Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$2.89B
/$0.52
Implied change from Q2 26 (Revenue/ EPS)
-2.27%
/-7.14%
Implied change from Q3 25 (Revenue/ EPS)
+2.03%
/-24.64%
Baxter International Inc. earnings per share and revenue
On Jul 30, 2026, BAX reported earnings of 0.56 USD per share (EPS) for Q2 26, beating the estimate of 0.36 USD, resulting in a 51.52% surprise. Revenue reached 2.96 billion, compared to an expected 2.82 billion, with a 4.84% difference. The market reacted with a +7.99% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of 0.52 USD, with revenue projected to reach 2.89 billion USD, implying an decrease of -7.14% EPS, and decrease of -2.27% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ResMed Inc.
Report Date
Aug 06, 2026 For Q4 26
Estimate
$2.91
Actual
$2.95
Surprise
+1.09%
ICU Medical Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.95
Actual
$2.37
Surprise
+21.43%
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
Prestige Consumer Healthcare Inc.
Report Date
Aug 06, 2026 For Q1 27
Estimate
$0.89
Actual
$0.98
Surprise
+10.01%
BioLife Solutions Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
InMode Ltd. Ordinary Shares
Report Date
Aug 05, 2026 For Q2 26
Estimate
$0.33
Actual
$0.35
Surprise
+3.15%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
Evolus, Inc. Common Stock
Report Date
Aug 05, 2026 For Q2 26
Estimate
-$0.03
Actual
$0.00
Surprise
+100.00%
TriSalus Life Sciences, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.16
Surprise
-1.20%
Apyx Medical Corporation Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+16.27%
FAQ
What were Baxter International Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Baxter International Inc. reported EPS of $0.56, beating estimates by 51.52%, and revenue of $2.96B, 4.84% above expectations.
How did the market react to Baxter International Inc.'s Q2 2026 earnings?
The stock price moved up 7.99%, changed from $24.77 before the earnings release to $26.75 the day after.
When is Baxter International Inc. expected to report next?
The next earning report is scheduled for Oct 28, 2026.
What are the forecasts for Baxter International Inc.'s next earnings report?
Based on 11
analysts, Baxter International Inc. is expected to report EPS of $0.52 and revenue of $2.89B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement